Introduction {#s001}
============

Current geriatric medicine is paying increasing attention to the identification of reliable mortality prognostic tools to improve clinical decision-making in diagnostics and therapeutics and to tailor appropriate interventions for the older frail patient.^[@B1]^

The prognosis of older subjects is strongly related to the presence of multimorbidity and to other factors, including physical, cognitive, biological, and social issues.^[@B2]^ In this context, a comprehensive geriatric assessment (CGA) seems to be capable to effectively explore all these domains and it is currently used to determine the prognosis of frail older persons.^[@B3],[@B4]^ Unfortunately, a recent systematic review of the most common prognostic tools in geriatric medicine identified very few mortality prognostic indices that meet the requirements of accuracy and calibration for their possible use in different settings.^[@B5]^

The multidimensional prognostic index (MPI)^[@B6]^ has been identified as a well-calibrated tool with a good discrimination and accuracy for short- and long-term mortality, both in hospital and community settings.^[@B7]^ The MPI is the only available prognostic tool based on information obtained from a CGA that explores not only health-related aspects, but also functional, cognitive, and nutritional domains, as well as cohabitation status, using standardized and extensively validated rating scales.^[@B6]^ Several studies showed that the MPI can predict short- and long-term mortality and other negative health outcomes in subjects with several chronic conditions, including heart failure,^[@B4]^ chronic kidney disease,^[@B8]^ diabetes mellitus,^[@B9]^ gastrointestinal diseases,^[@B10]^ neurological diseases,^[@B11]^ cancer,^[@B12]^ and dementia.^[@B13]^

However, the self-perception of health status is another important aspect to consider. Self-assessment instruments have been validated in different contexts (*e.g.*, self-reported body mass index)^[@B14]^ and have been widely used in epidemiological research, particularly as screening tools, because of their practicality, range, speed, and low cost.^[@B15]^ In this regard, self-perception of frailty allows expanded screening for this syndrome, to have an important tool for the early diagnosis of frailty itself.^[@B16]^ Nevertheless, we have limited data on self-reported tools to assess frailty in older people^[@B17]^ and the available ones are mainly based on the criteria proposed by Fried et al., which may identify physical frailty only.^[@B18]^

At the same time, robust evidence exists on the great influence of social determinants on health and the development of chronic diseases. Many research articles have demonstrated that socioeconomic and cultural differences can produce short- and long-term inequalities in health care and self-care behavior, both essential dimensions for the prevention and management of chronic conditions.^[@B19]^ The MPI, differently from the common tools for assessing frailty in older people, is able to include all these relevant aspects.^[@B6]^

Given this background, the aim of this study was to develop a self-administered MPI (SELFY-MPI) for community-dwelling subjects. Moreover, we aimed to validate the SELFY-MPI compared with the standard MPI, that is, calculated after a CGA by a health care professional.

Methods {#s002}
=======

Study design and population {#s003}
---------------------------

This study is an observational study conducted between December 2017 and April 2018 according to the World Medical Association\'s 2008 Declaration of Helsinki, the guidelines for Good Clinical Practice, and the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.^[@B20]^

This research was performed in the context of the ongoing project/joint action "738127/EFFICHRONIC," which has received funding from the European Union\'s Health Programme (2014--2020)." The project EFFICHRONIC aims to provide evidence on the positive return of investment and cost-efficiency of the application of the Chronic Disease Self-Management Programme in five different European countries (France, Italy, Spain, The Netherlands, and United Kingdom) with a particular focus on the health, medical, social, cultural, and economic factors linked with a higher burden of chronic disorders in Europe (<http://effichronic.eu>).

Inclusion criteria were subjects (1) who attended the outpatient clinics of the Galliera Hospital, (2) without acute and emergency clinical conditions, (3) who are living in community, (4) who are capable to provide an informed consent (as decided by the research evaluating the participant) or have the availability of a proxy for informed consent, (5) who are willing to participate in the study, and (6) who have had a complete CGA by a health care professional.

The Ethical Committee of the Liguria Region, Genoa, Italy approved this study. Informed consent was given by participants who underwent initial evaluation, and/or their proxies, for their clinical records to be used in this study. All patient records and personal information were anonymized before the statistical analysis.

Multidimensional prognostic index {#s004}
---------------------------------

The MPI was calculated with the information from eight different domains of the CGA as previously reported^[@B6]^: 1.Functional status was evaluated through the Katz\'s activities of daily living (ADL) index,^[@B21]^ which defines the level of independence in six daily personal care activities (bathing, toileting, feeding, dressing, continence, and transferring in and out of bed or chair).2.Independence was measured by means of the Lawton\'s instrumental activities of daily living (IADL)^[@B22]^ scale, which assesses independence in eight activities that are more cognitively and physically demanding than the ADL, that is, managing finances, using a telephone, taking medications, shopping, using transportation, preparing meals, doing housework, and washing.3.Cognitive status was determined through the short portable mental status questionnaire,^[@B23]^ a 10-item questionnaire investigating orientation, memory, attention, calculation, and language.4.Comorbidity was examined using the cumulative illness rating scale (CIRS),^[@B24]^ a five-point ordinal scale (score 1--5) to estimate the severity of pathology in each of 13 systems, including cardiac, vascular, respiratory, eye-ear-nose-throat, upper and lower gastrointestinal, hepatic, renal, genitourinary, musculoskeletal, skin, nervous system, endocrine-metabolic, and psychiatric disorders. Based on the ratings, the comorbidity index (CIRS-CI) score, which reflects the number of concomitant diseases, was derived from the total number of categories in which moderate or severe levels (grade from 3 to 5) of disease were identified (range from 0 to 13). Comorbidities were descriptively reported using the International Classification of Disease, 10th version.^[@B25]^5.Nutritional status was investigated with the Mini Nutritional Assessment Short Form (MNA-SF),^[@B26]^ which includes information on (i) anthropometric measures (body mass index and weight loss), (ii) neuropsychological problems and recent psychological stress, (iii) mobility, and (iv) decline in food intake.6.Risk of developing pressure sores was evaluated through the Exton-Smith Scale, a five-item questionnaire determining physical and mental condition, activity, mobility, and incontinence.^[@B27]^7.Medication use was defined according to the Anatomical Therapeutics Chemical Classification code system (ATC classification) and the number of drugs used by patients was recorded. Patients were defined as being on medication if they were taking any of the drugs included in the ATC classification at the moment of study inclusion.8.Cohabitation status included living alone, in an institution, or with family members.

For each domain, a tripartite hierarchy was used,^[@B6]^ that is, 0 = no problems, 0.5 = minor problems, and 1 = major problems, based on conventional cutoff points derived from literature for the singular items. The sum of the calculated scores from the eight domains was divided by 8 to obtain a final MPI risk score ranging from 0 = no risk to 1 = higher risk of mortality. The MPI requires between 15 and 25 minutes for its complete execution and the results can be automatically obtained through the MPI calculator software downloadable from the [www.mpiage.eu](www.mpiage.eu) website. For this study, the MPI was calculated after a trained health care professional performed a CGA.

Self-administered-MPI {#s005}
---------------------

Similarly to the domains of the MPI,^[@B6]^ the SELFY-MPI considered the following domains:

1.  Functional status assessed through the Barthel ADL^[@B28]^ scale that includes the ability in feeding, bathing, personal hygiene, dressing, fecal and urinary continence, and toilet use. This scale can be self-administered.^[@B29]^

2.  Mobility assessed through the Barthel Mobility^[@B28]^ scale that includes transfer from bed to chair or wheelchair, walking and going up and down the stairs. This scale can be self-administered.^[@B29]^

3.  Independence by means of the Lawton\'s IADL^[@B22]^ scale, as reported earlier. It is also possible to self-administer this scale.^[@B30]^

4.  Cognitive status assessed through the self-administered cognitive screening test (test your memory).^[@B31]^ It is a validated 10-task cognitive test exploring several domains, including memory, semantic knowledge, and visuospatial skills. The score ranges from 0 to 50, higher scores indicating better cognitive function.^[@B31]^

5.  Nutritional status investigated with the MNA-SF,^[@B26]^ as reported in the previous paragraph. A validated self-administered MNA-SF was used.^[@B32]^

6.  Number of medications.

7.  Comorbidity: CIRS comorbidity is the number of health problems/diseases that are so severe to require chronic drug therapies in 13 aspects of health.^[@B25]^ CIRS can be consequently self-assessed by reporting health problems/diseases that require medications for their treatment.

8.  Socioeconomic variables were assessed through the self-administered Gijon\'s social-familial evaluation scale, with a maximum score of 25 points. Scores between 10 and 14 indicate being at social risk and scores \>15, social problems.^[@B33]^ The Gijon scale considers socioeconomic variables, exploring (i) household composition, (ii) the net monthly household income, (iii) housing and personal needs, (iv) social relationships, and (v) social support of the subject.

Similarly to the MPI,^[@B6]^ a tripartite hierarchy was used and reported in [Table 1](#T1){ref-type="table"}. The sum of the calculated scores from the eight domains was divided by 8 to obtain a final SELFY-MPI risk score ranging from 0 = no risk to 1 = high risk of mortality. The median (interquartile range \[IQR\]) time required to complete the SELFY-MPI was 16 minutes (range from 9 to 36 minutes).

###### 

Domains of the Self-Administered-MPI and Its Scoring

  *SELFY-MPI*                                                                                            
  -------------------- --------------------------------------------------------------- -------- -------- ---
  Barthel ADL          0--14                                                           15--49   50--60    
  Barthel MOB          0--14                                                           15--29   30--40    
  IADL                 8--6                                                            5--4     3--0      
  TYM                  50--43                                                          42--24   23--0     
  MNA-SF               14--12                                                          11--8    7--0      
  No. of medications   0--3                                                            4--6     ≥7        
  CIRS                 0                                                               1--2     3--13     
  SFES                 5--9                                                            10--14   15--25    
  Total                Summarize the numbers assigned to each domain and divide by 8                     

ADL, activities of daily living; CIRS, Cumulative Illness Rating Scale; IADL, instrumental activities of daily living; MNA-SF, Mini Nutritional Assessment Short Form; MOB, mobility; MPI, multidimensional prognostic index; SELFY-MPI, self-administered MPI; SFES, Gijon\'s social-familial evaluation scale; TYM: test your memory.

Statistical analysis {#s006}
--------------------

Main descriptive statistics were absolute and relative (%) frequencies; mean; standard deviation (SD); median; and minimum, maximum, and IQR. Mean differences were tested using the paired sample *t*-test. Although scatter plots are an excellent way of examining the correlation between two outcomes, it is an insensitive method to assess the agreement between two continuous measures. In this regard, we adopted the Bland--Altman plot (BAP)^[@B34]^ methodology, which provides an objective measure (95% limits of agreement) and a visual representation (plot of the difference vs. the mean of the two measures) of the level of agreement between two different measures. To detect possible differences in the level of agreement by age, we performed a BAP analysis stratified by deciles of age.

We reported two-tailed probabilities, and a *p*-value of 0.05 was adopted to define nominal statistical significance. All analyses were conducted using the software STATA (version 14.2; StataCorp., College Station, TX).

Results {#s007}
=======

We enrolled 167 subjects with a mean (SD) age of 67.3 (18.8) years (range: 19--88 years) and a slightly higher prevalence of men (50.9%), as reported in [Table 2](#T2){ref-type="table"}. In this cohort, mean (SD) MPI and SELFY-MPI values were 0.147 (0.112) and 0.145 (0.118), respectively. The mean difference between MPI and SELFY-MPI values was +0.002 (0.07) (*p* = 0.70). No significant differences emerged for any test included in the MPI (details not shown, available upon request).

###### 

Patients\' Characteristics

  -------------------------------- -------------------
  Age, years                       
   Mean (SD)                       67.3 (18.8)
   Median (IQR)                    76 (56--79)
   Min/max                         19/88
  Gender, *n* (%)                  
   Men                             85 (50.9)
   Women                           82 (49.1)
  MPI                              
   Mean (SD)                       0.147 (0.112)
   Median (IQR)                    0.13 (0.06--0.19)
   Min/max                         0.0/0.5
  SELFY-MPI                        
   Mean (SD)                       0.145 (0.118)
   Median (IQR)                    0.12 (0.06--0.25)
   Min/max                         0.0/0.5
  Difference (MPI) − (SELFY-MPI)   
   Mean (SD)                       +0.002 (0.07)
   Median (IQR)                    0.0 (−0.06--0.06)
   Min/max                         −0.31/0.19
  -------------------------------- -------------------

IQR, interquartile range; SD, standard deviation.

Hypertension was present in 62/167 patients ( = 37.1%), cardiovascular diseases in 27 ( = 16.1%), and gastroenteric conditions in 21 ( = 12.6%) patients. The other conditions (liver, kidney, and genitourinary conditions) were less frequent.

[Figure 1](#f1){ref-type="fig"} shows the BAPs for the association between the MPI and the SELFY-MPI. Lower and upper 95% limits of agreement were −0.135 and +0.139, respectively, with only 5 of 167 (3.0%) of observations outside the limits.

![BAP of agreement between MPI and SELFY-MPI. BAP, Bland--Altman plot; MPI, multidimensional prognostic index; SELFY-MPI, self-administered MPI.](fig-1){#f1}

[Figure 2](#f2){ref-type="fig"} shows the BAPs stratified by age. In 45 subjects aged \<66 years, the mean (SD) difference between the MPI and SELFY-MPI values was -0.011 (0.042), with the lower and upper 95% limits of agreement of −0.095 and +0.072. Only 2/45 (4.4%) resulted outside of the limits of agreement ([Fig. 2A](#f2){ref-type="fig"}). Similarly, in 122 participants older than 65 years, the mean (SD) difference was 0.007 (0.077) with the lower and upper 95% limits of agreement of −0.144 and +0.158. Five participants (4.1%) were outside the limits of agreement ([Fig. 2B](#f2){ref-type="fig"}).

![BAP of agreement between MPI and SELFY-MPI in people younger **(A)** and older **(B)** than 65 years.](fig-2){#f2}

Finally, as shown in [Figure 3](#f3){ref-type="fig"}, we performed a stratified analysis of agreement among subgroups of patients by deciles of age. The line represents the fluctuation of the difference between MPI and SELFY-MPI moving from lower to upper deciles of age; no significant differences between MPI and SELFY-MPI, throughout all the age categories, nor significant interactions or trends with age were detected.

![Agreement between MPI and SELFY-MPI in subjects subdivided according to decades of age.](fig-3){#f3}

Discussion {#s008}
==========

In this study, we evaluate a new instrument to assess the MPI through a self-administered tool. The SELFY-MPI showed a strong validity when compared with the standard MPI calculated by a trained health care professional in 167 community-dwelling persons between 19 and 88 years of age.

From a methodological point of view, we observed a very small and not clinically significant overestimation (in mean only 0.002 points) between SELFY-MPI and MPI in the sample. In this sense, through the BAPs,^[@B34]^ we showed that the distance between the upper and lower margins is not large enough to be clinically important having, in the sample as a whole, only five persons outside the limits of agreement. Finally, the agreement between SELFY-MPI and MPI resulted very similar in people having less or more than 65 years of age, suggesting that our results are not influenced by age, as also further confirmed by the variability around the mean that was constant for the included decades.

The development of prognostic tools that are appropriate for the evaluation of patients with chronic diseases is of great clinical importance, particularly to further consider life expectancy as a relevant factor in weighing the benefits and the burdens of both diagnostic and therapeutic interventions.^[@B35]^ In this sense, prognostic indices may result to be important tools to the clinician for the better understanding of appropriate clinical decision-making, in particular in frail and multimorbid adults.^[@B2]^ In fact, it is widely known that not to consider prognosis in clinical decision-making can lead to poor care.^[@B4]^

The MPI has been developed and validated in a very large cohort of older patients hospitalized for any cause.^[@B6]^ Its role was both confirmed in other settings (in institutionalized, community-dwelling subjects, and outpatients) and in patients with different chronic diseases, that is, heart failure, chronic renal failure, diabetes mellitus, liver cirrhosis, dementia, and transient ischemic attack.^[@B39],[@B40]^ A previous multicenter study involving \>2000 hospitalized older patients has reported that the MPI is a more accurate prognostic predictor than three frailty indices commonly used for mortality in clinical practice.^[@B41]^ Finally, the prognostic role of the MPI was also confirmed in older community-dwelling subjects,^[@B42]^ suggesting that it can also easily be used in nonhospitalized older people.

However, our work reporting the strong association and validity of the SELFY-MPI compared with the standard MPI adds something more to this important topic. So far, the self-administered tools for assessing frailty and the risk of death described in literature are practically only for screening purposes. In a systematic review published in 2012, the authors found a total of 10 instruments screening for frailty in primary health and they concluded that, based on the data available, two instruments are probably suitable, that is, the Tilburg Frailty Indicator and the SHARE Frailty Index.^[@B17]^ However, for these two specific instruments, the agreement with a validated scale of frailty was not reported suggesting that more research is needed to confirm the use of these tools in daily clinical practice.^[@B17]^ More recently, Morley et al. proposed the fatigue, resistance, ambulation, illnesses, and loss of weight (FRAIL) questionnaire^[@B43]^ that is mainly based on the criteria proposed by Fried et al.^[@B18]^ Therefore, as the original score, the FRAIL questionnaire suffers some important shortcomings, including the absence of cognitive status assessment, the fact that it was validated in a specific ethnic minority (*i.e.*, African Americans) and that the scale proposed by Fried et al. investigates frailty only in terms of physical impairment.^[@B44]^ Thus, the SELFY-MPI can add some novel findings in this important topic since, as the MPI, it includes several domains important for frailty such as comorbidity, social aspects, cognition, and functional status. Furthermore, the SELFY-MPI adds a new socioeconomic dimension to the MPI by means of the Gijon scale. In this way, it can contribute to a holistic approach of patients considering the socioeconomic domain as one of the widely recognized determinants of health.

The findings of our study should be interpreted within its limitations. First, the cohort included is relatively small, including 167 participants. Second, the nature of our study is cross-sectional. Even if we found a strong association between SELFY-MPI and MPI, further longitudinal studies are needed to confirm if the SELFY-MPI is able to predict mortality with the same accuracy as the MPI. On the contrary, among the strengths of our work, we can include the strong validity of this score having only 5 subjects of 167 outside of the limits of agreement and the fact that this tool is extremely quick to do, needing \<20 minutes.

In conclusion, the SELFY-MPI can be used as a predictive tool having a strong validity when compared with the MPI. These findings were not influenced by age suggesting that this tool can be used indifferently in younger and older people. Future studies are needed to confirm these findings and to verify if the SELFY-MPI has the same accuracy as the MPI in predicting death and other negative outcomes.
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